1. Home
  2. CASI vs MBBC Comparison

CASI vs MBBC Comparison

Compare CASI & MBBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASI
  • MBBC
  • Stock Information
  • Founded
  • CASI 1991
  • MBBC 1902
  • Country
  • CASI China
  • MBBC United States
  • Employees
  • CASI N/A
  • MBBC N/A
  • Industry
  • CASI Biotechnology: Pharmaceutical Preparations
  • MBBC Banks
  • Sector
  • CASI Health Care
  • MBBC Finance
  • Exchange
  • CASI Nasdaq
  • MBBC Nasdaq
  • Market Cap
  • CASI 35.8M
  • MBBC 30.4M
  • IPO Year
  • CASI 1996
  • MBBC N/A
  • Fundamental
  • Price
  • CASI $2.28
  • MBBC $10.25
  • Analyst Decision
  • CASI Strong Buy
  • MBBC
  • Analyst Count
  • CASI 1
  • MBBC 0
  • Target Price
  • CASI $4.00
  • MBBC N/A
  • AVG Volume (30 Days)
  • CASI 384.8K
  • MBBC 4.4K
  • Earning Date
  • CASI 11-13-2025
  • MBBC 09-24-2025
  • Dividend Yield
  • CASI N/A
  • MBBC N/A
  • EPS Growth
  • CASI N/A
  • MBBC 103.56
  • EPS
  • CASI N/A
  • MBBC 0.22
  • Revenue
  • CASI $31,564,000.00
  • MBBC $6,591,743.00
  • Revenue This Year
  • CASI N/A
  • MBBC N/A
  • Revenue Next Year
  • CASI N/A
  • MBBC N/A
  • P/E Ratio
  • CASI N/A
  • MBBC $46.54
  • Revenue Growth
  • CASI 36.64
  • MBBC N/A
  • 52 Week Low
  • CASI $1.09
  • MBBC $6.42
  • 52 Week High
  • CASI $7.55
  • MBBC $12.00
  • Technical
  • Relative Strength Index (RSI)
  • CASI 55.66
  • MBBC N/A
  • Support Level
  • CASI $2.18
  • MBBC N/A
  • Resistance Level
  • CASI $2.49
  • MBBC N/A
  • Average True Range (ATR)
  • CASI 0.19
  • MBBC 0.00
  • MACD
  • CASI -0.03
  • MBBC 0.00
  • Stochastic Oscillator
  • CASI 33.33
  • MBBC 0.00

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

About MBBC Marathon Bancorp Inc. Common Stock

Marathon Bancorp Inc is a Wisconsin-chartered savings bank. It is a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the Company's revenues come from interest income on loans and debt securities.

Share on Social Networks: